The COVID‐19 pandemic transformed everyday life, but the implications were most
impactful for vulnerable populations, including patients with chronic pain. Moreover …

Over the past few decades, substantial advances have been made in neuropathic pain
clinical research. An updated definition and classification have been agreed. Validated …

Objectives. To investigate the prevalence of neuropathic pain symptoms and to analyze the
correlation between neuropathic symptoms with pain‐related, psychological, and cognitive …

We compared the prevalence of musculoskeletal post-COVID pain between previously
hospitalized COVID-19 survivors infected with the historical, Alpha or Delta SARS-CoV-2 …

Background Pain after a SARS‐CoV‐2 acute infection (post‐COVID pain) is becoming a
new healthcare emergency but remains underestimated and most likely undertreated due to …

Background New‐onset chronic pain has been acknowledged as part of the post‐COVID‐19
condition. However, available fine‐grained data about its clinical phenotype, trajectories and …

This multicenter cohort study investigated the prevalence of musculoskeletal post-COVID
pain during the first year after the infection with mosaic plots and an exponential bar plot …

A better understanding of biological and emotional variables associated with health-related
quality of life in people with long-COVID is needed. Our aim was to identify potential direct …

The aim of this study was to evaluate the characteristics of pain (ie, pain intensity, pain
interference, clinical presentation) in Long-COVID-19 patients and compare the location of …

Abstract Background and Objective Neuropathic pain is an occasionally reported
complication of coronavirus disease 2019 (COVID‐19) that has received increased attention …